TLDR: Everyone’s talking about what the money could do, but few about how to decide where it goes.
This post is part of the new series of articles on cross-cause giving and the new wave of philanthropy. Stay tuned to the EA Forum and our Substack for the latest takes on topics such as giving now vs. later, common pitfalls in cause prioritization, and other crucial considerations from the Cross-Cause Fund (CCF) team...
I was born at the end of the cold war, unaware of the danger we were emerging from. Duck and cover drills (as if those could protect schoolchildren from a nuclear blast) were a curiosity of the past.
The farmer-poet Wendell Berry, who wrote about the dread of nuclear war, died recently. From his 1968 “The peace of wild things”:
When despair for the world grows in me
and I wake in the night at the least...
New anti-malaria treatment clears phase 3 trials.
I just found that there is a new anti-malarial alternative to artemisinin, the most common antimalarial chemical, which has successfully completed Phase 3 trials. Its nickname is GanLum and apparently has quite powerful effects:
This is an important advance because resistance to artemisinin is one of the growing concerns in the fight against malaria.
You may read more in https://www.npr.org/sections/goats-and-soda/2025/11/12/g-s1-97487/malaria-drug-new and https://www.mmv.org/newsroom/news-resources-search/phase-3-trial-next-generation-malaria-treatment-ganaplacide-lumefantrine .
Very interesting! And very hopeful! Thanks for sharing!